These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 3987836

  • 1. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP, Buffo MJ, Kociban DL.
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [Abstract] [Full Text] [Related]

  • 2. Leukopenia and altered hematopoietic activity in mice exposed to the abused inhalant, isobutyl nitrite.
    Soderberg LS, Flick JT, Barnett JB.
    Exp Hematol; 1996 Jun; 24(7):848-53. PubMed ID: 8647236
    [Abstract] [Full Text] [Related]

  • 3. Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.
    Huybrechts M, Symann M, Trouet A.
    Cancer Res; 1979 Sep; 39(9):3738-43. PubMed ID: 476697
    [Abstract] [Full Text] [Related]

  • 4. Methods for measuring suppression of hematopoiesis.
    Chervenick PA.
    Exp Hematol; 1985 Sep; 13 Suppl 16():8-15. PubMed ID: 3987838
    [Abstract] [Full Text] [Related]

  • 5. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N, Chertkov J, Samoilina N, Zander A.
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE, Hannon EC, Vigneulle R, Hellman S.
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [Abstract] [Full Text] [Related]

  • 7. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
    Kovacs CJ, Johnke RM, Evans MJ, Emma DA, Hooker JL.
    Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928
    [Abstract] [Full Text] [Related]

  • 8. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of benzene inhalation on murine hematopoietic precursor cells (CFU-e, BFU-e and CFU-gm).
    Hilderbrand RL, Murphy MJ.
    Int J Cell Cloning; 1983 Sep; 1(4):240-53. PubMed ID: 6668429
    [Abstract] [Full Text] [Related]

  • 11. Effect of prolonged expansion of marrow progenitor compartments following doxorubicin (ADR) on subsequent radiation tolerance.
    Kovacs CJ, Johnke RM, Emma DA, Scarantino CW.
    Exp Hematol; 1985 Sep; 13 Suppl 16():89-94. PubMed ID: 3987840
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dynamics of leukemic and normal stem cells in leukemic RFM mice.
    Husseini S, Fried W, Knospe WH, Trobaugh FE.
    Cancer Res; 1976 May; 36(5):1784-9. PubMed ID: 1268835
    [Abstract] [Full Text] [Related]

  • 14. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
    Loeffler M, Bungart B, Goris H, Schmitz S, Nijhof W.
    Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and in vivo.
    Laerum OD, Paukovits WR.
    Exp Hematol; 1984 Jan; 12(1):7-17. PubMed ID: 6230248
    [Abstract] [Full Text] [Related]

  • 16. Lithium and hematopoietic toxicity. I. Recovery in vivo of murine hematopoietic stem cells (CFU-S and CFU-Mix) after single-dose administration of cyclophosphamide.
    Gallicchio VS.
    Exp Hematol; 1986 Jun; 14(5):395-400. PubMed ID: 3709709
    [Abstract] [Full Text] [Related]

  • 17. Antiserum to mouse hematopoietic pluripotent stem cells (CFU-S): further investigation of its functional properties.
    Kuznetsky RD, Trobaugh FE, Adler SS.
    Exp Hematol; 1979 Aug; 7(7):369-76. PubMed ID: 488193
    [Abstract] [Full Text] [Related]

  • 18. Lithium and hematopoietic toxicity. II. Acceleration in vivo of murine hematopoietic progenitor cells (CFU-gm and CFU-meg) following treatment with vinblastine sulfate.
    Gallicchio VS.
    Int J Cell Cloning; 1987 Mar; 5(2):122-33. PubMed ID: 3572050
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.